Evidence map›Paper›PMID 22508856›Full record

ArticleInfection and immunity2012

Members of the Francisella tularensis phagosomal transporter subfamily of major facilitator superfamily transporters are critical for pathogenesis.

Mark E Marohn, Araceli E Santiago, Kari Ann Shirey, Michael Lipsky, Stefanie N Vogel, Eileen M Barry

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Deletion Mutants ofPathogens (Basel, Switzerland) · 2021
    Article
  3. Article
  4. Article
  5. Population Genomics ofFrontiers in cellular and infection microbiology · 2018
    Article
  6. Importance of Metabolic Adaptations inFrontiers in cellular and infection microbiology · 2017
    Review
  7. Article
  8. The complex amino acid diet of Francisella in infected macrophages.Frontiers in cellular and infection microbiology · 2015
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Uncovering the components of the Francisella tularensis virulence stealth strategy.Frontiers in cellular and infection microbiology · 2014
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mark E MarohnUniversity of Maryland School of Medicine, Baltimore, Maryland, USA.
Araceli E Santiago
Kari Ann Shirey
Michael Lipsky
Stefanie N Vogel
Eileen M Barry
University of Maryland, Baltimore · USUniversity of Virginia · US

Funding

Vaccine strategy for broad spectrum protection agains non-typhoidal salmonellU54AI057168 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI ROTHMAN, RICHARD E · 2003 to 2013
$91.5M
Advancement of New Live Attenuated F. Tularensis Type A Vaccine StrainsU01AI077909 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BARRY, EILEEN M. · 2009 to 2010
$1.1M
NIAID NIH HHS U01 AI077909NIAID NIH HHS U54 AI057168
6 · The paper itself

Abstract

Francisella tularensis is the causative agent of tularemia. Due to its aerosolizable nature and low infectious dose, F. tularensis is classified as a category A select agent and, therefore, is a priority for vaccine development. Survival and replication in macrophages and other cell types are critical to F. tularensis pathogenesis, and impaired intracellular survival has been linked to a reduction in virulence. The F. tularensis genome is predicted to encode 31 major facilitator superfamily (MFS) transporters, and the nine-member Francisella phagosomal transporter (Fpt) subfamily possesses homology with virulence factors in other intracellular pathogens. We hypothesized that these MFS transporters may play an important role in F. tularensis pathogenesis and serve as good targets for attenuation and vaccine development. Here we show altered intracellular replication kinetics and attenuation of virulence in mice infected with three of the nine Fpt mutant strains compared with wild-type (WT) F. tularensis LVS. The vaccination of mice with these mutant strains was protective against a lethal intraperitoneal challenge. Additionally, we observed pronounced differences in cytokine profiles in the livers of mutant-infected mice, suggesting that alterations in in vivo cytokine responses are a major contributor to the attenuation observed for these mutant strains. These results confirm that this subset of MFS transporters plays an important role in the pathogenesis of F. tularensis and suggest that a focus on the development of attenuated Fpt subfamily MFS transporter mutants is a viable strategy toward the development of an efficacious vaccine.

Indexed as

AnimalsBacterial VaccinesDisease Models, AnimalFemaleFrancisella tularensisMacrophagesMembrane Transport ProteinsMiceMice, Inbred BALB CPhagosomesSurvival AnalysisTularemiaVirulenceVirulence FactorsBacterial VaccinesMembrane Transport ProteinsVirulence Factors

Identifiers

PMID22508856
PMCPMC3416476
OpenAlexW2106486326

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.